Sufentanil Citrate (Hospira, Inc.)


Welcome to the PulseAid listing for the Sufentanil Citrate drug offered from Hospira, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: SUFENTANIL CITRATE
SUBSTANCE NAME: SUFENTANIL CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
ROUTE: EPIDURAL; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-09-07
END MARKETING DATE: 0000-00-00


Sufentanil Citrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSufentanil Citrate from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE: CII
ACTIVE STRENGTH: 50(ug/mL)
START MARKETING DATE: 2005-09-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-3380_1aab2d47-62d1-4fc7-ba5e-f92a5e6262a9
PRODUCT NDC: 0409-3380
APPLICATION NUMBER: ANDA074534

Other SUFENTANIL CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Sufentanil Citrate
Hospira, Inc.Sufentanil Citrate
West-ward Pharmaceutical Corp.Sufentanil Citrate